The purpose of this study is to explore areas of discrimination experienced by our community of providers as well as determining areas of implicit bias that may affect how we practice medicine. By confronting and understanding these issues we can better understand our American Urogynecologic Society (AUGS) community and improve the care we provide all women with pelvic floor disorders.

The purpose of this study is to test a program to help people who have knee or hip osteoarthritis (OA) to increase their physical activity (PA).

The purpose of this study is to examine 4 different therapeutic approaches towards improving the 3 year event free survival from 6% to 35% in newly diagnosed metastatic Rhabdomyosarcoma patients.

Outcome measures are ways we tell how well babies are doing in the hospital or after going home. Outcome measures used in research may not be the best. One reason is that medications, devices, or care practices can affect many different organ systems, so it is important evaluate more than one area. Another is deciding whether to measure outcomes while the infant is still in the hospital or to wait see how the infant is doing after going home. That decision is complex; one consideration is that some families cannot be reached after going home and their valuable information is lost. Finally, researchers and doctors often view outcomes differently than families. While it is important researchers and doctors make sure outcomes are valid and medically relevant, it is just as important to understand parents' and caregivers' opinions on outcome measures.

We are looking to identify proteins in the blood that may contribute to scarring of a heart valve

Our goal is to compare the research experiences of people who are in the Accelerated Research Program at UNC to people who are not in the program to see how well the program is working.

To assess how the Medical Staff of UNC view interventions to prevent COVID acquisition

This is a multicenter, open-label study to study the safety and characteristics of DNL310, an investigational drug designed to treat both the body and brain manifestations of Mucopolysaccharidosis type II (MPS II; Hunter syndrome). The plan is for each participant to start at a low dose and increase over time until a final dose is achieved. Blood, urine and CSF samples will be taken, and tests and assessments will be done to see how your child is doing in the study.

To determine whether newly-developed naloxone training materials increase how often pharmacists dispense naloxone.

The primary purpose of this research study is to learn about how the level of a protein called p16 changes in the blood of children, adolescents, and adults with sickle cell disease. This protein can provide information about cellular aging which has not been studied before in patients with sickle cell disease. This can help develop future areas of research into sickle cell disease.